Related references
Note: Only part of the references are listed.The Role of M1/M2 Macrophage Polarization in Rheumatoid Arthritis Synovitis
Maurizio Cutolo et al.
FRONTIERS IN IMMUNOLOGY (2022)
Critical Role of Synovial Tissue-Resident Macrophage and Fibroblast Subsets in the Persistence of Joint Inflammation
Samuel Kemble et al.
FRONTIERS IN IMMUNOLOGY (2021)
The Role of Inflammation in the Pathogenesis of Osteoarthritis
Yoke Yue Chow et al.
MEDIATORS OF INFLAMMATION (2020)
Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update on Ovarian Suppression
Harold J. Burstein et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
A chimeric human-mouse model of Sjogren's syndrome
Nicholas A. Young et al.
CLINICAL IMMUNOLOGY (2015)
Estrogen modulation of endosome-associated toll-like receptor 8: An IFNα-independent mechanism of sex-bias in systemic lupus erythematosus
Nicholas A. Young et al.
CLINICAL IMMUNOLOGY (2014)
Oral Administration of Nano-Emulsion Curcumin in Mice Suppresses Inflammatory-Induced NFκB Signaling and Macrophage Migration
Nicholas A. Young et al.
PLOS ONE (2014)
Molecular mechanisms that influence the macrophage M1-M2 polarization balance
Nan Wang et al.
FRONTIERS IN IMMUNOLOGY (2014)
Aromatase inhibitor-induced arthralgia: a review
P. Niravath
ANNALS OF ONCOLOGY (2013)
Aberrant Muscle Antigen Exposure in Mice Is Sufficient to Cause Myositis in a Treg Cell-Deficient Milieu
Nicholas A. Young et al.
ARTHRITIS AND RHEUMATISM (2013)
Impact of body mass index on estradiol depletion by aromatase inhibitors in postmenopausal women with early breast cancer
G. Pfeiler et al.
BRITISH JOURNAL OF CANCER (2013)
Interleukin-2 at the Crossroads of Effector Responses, Tolerance, and Immunotherapy
Wei Liao et al.
IMMUNITY (2013)
Targeting monocytes/macrophages in the treatment of rheumatoid arthritis
Jean-Luc Davignon et al.
RHEUMATOLOGY (2013)
Aromatase inhibitor-induced arthralgia in early breast cancer: what do we know and how can we find out more?
Omar S. Din et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
American Society of Clinical Oncology Clinical Practice Guideline: Update on Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer
Harold J. Burstein et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
American Society of Clinical Oncology Clinical Practice Guideline Update on Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer
Harold J. Burstein et al.
JOURNAL OF ONCOLOGY PRACTICE (2010)
Oestrogen exhibits type II collagen protective effects and attenuates collagen-induced arthritis in rats
R. H. Nielsen et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2008)
Prospective characterization of musculoskeletal symptoms in early stage breast cancer patients treated with aromatase inhibitors
N. Lynn Henry et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Aromatase inhibitor-associated arthralgia and/or bone pain: Frequency and characterization in non-clinical trial patients
Cary A. Presant et al.
CLINICAL BREAST CANCER (2007)
Prevalence of joint symptoms in postmenopausal women taking aromatase inhibitors for early-stage breast cancer
Katherine D. Crew et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
The complex role of estrogens in inflammation
Rainer H. Straub
ENDOCRINE REVIEWS (2007)
Effect of hormone therapy on risk of hip and knee joint replacement in the women's health initiative
Dominic J. Cirillo et al.
ARTHRITIS AND RHEUMATISM (2006)
A novel method of monitoring response to islet transplantation: Bioluminescent imaging of an NF-kB transgenic mouse model
DJ Roth et al.
TRANSPLANTATION (2006)
Targeted immunomodulation of the NF-κB pathway in airway epithelium impacts host defense against Pseudomonas aeruginosa
Ruxana T. Sadikot et al.
JOURNAL OF IMMUNOLOGY (2006)
Quality of life in the intergroup exemestane study: A randomized trial of exemestane versus continued tamoxifen after 2 to 3 years of tamoxifen in postmenopausal women with primary breast cancer
LJ Fallowfield et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Share Paper
